Centene Corporation (CNC) is a new-age multi-national healthcare solutions provider from the United States, specializing in the administration and implementation of healthcare programs and services. Founded in 1984 by Elizabeth ‘Betty’ Brinn, the company has its headquarters situated in the heart of St. Louis, Missouri. CNC's steady culmination to predominance boasts an annual revenue of over $100 billion, marking its territory as one of the largest players in the healthcare sector.
Centene's strategic service framework encompasses a broad spectrum of healthcare programs, including Medicaid and Medicare. This Fortune 100 company targets uninsured individuals and those who are under-insured, offering them a lifeboat of reasonable health coverage. CNC operates nationwide, providing coverage to over 23 million members across an impressive 50 states.
Centene follows a unique business model aimed at bridging the gap between the underprivileged and quality healthcare. The company operates with a mantra, "Better Health Outcomes at Lower Costs". True to its motto, they follow the local approach and work hand-in-hand with the community, creating jobs and promoting healthy lifestyle initiatives amongst locals. Their widespread portfolio of services makes them a one-stop shop for healthcare services, ranging from behavioral health, substance use disorders, specialty pharmacy services, to telehealth.
Centene Corporation’s successful business module has fortified its position in the healthcare industry. It continues to reinvent and adapt its offerings in line with the market’s evolving needs and the government's healthcare policies. Notable acquisitions, like WellCare Health Plans in 2020, have exponentially broadened CNC's market reach, thereby consolidating its leading position in the sector.
A company committed to ESG (environmental, social, governance) principles, Centene is dedicated to reducing its environmental impact and ensuring sustainable business practices. It has bagged numerous accolades favoring its relentless pursuit to make healthcare affordable and accessible for all, including a place in the Dow Jones Sustainability North America Index and its prestigious Gold level status in the American Health Association's Workplace Health Achievement Index.
Being a crucial player in the healthcare sector, Centene also diligently participates in various philanthropic initiatives. Through the Centene Charitable Foundation, the corporation provides grants to non-profit organizations that share its vision of providing community-based health outcomes.
In summary, Centene Corporation is not just a market leader in the American healthcare space, but it's a stalwart that believes in impactful social change through affordable and accessible quality healthcare. With its innovative approach, tenacity for growth, and its commitment to bettering lives, CNC is an indisputable heavyweight in its sector.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
CVS Health's Aetna division is projected to reach an adjusted operating income of $5.37 billion in 2026, which merely returns it to 2021 levels after a significant drop in 2024. The article highlights a concern that AI tools used by providers are identifying more billable diagnoses without a corresponding increase in treatment, potentially driving up healthcare costs. This trend, already noted by other insurers, could impact Aetna's medical cost trends and leaves CVS with a thin cushion given its 2027 EPS consensus is only slightly above management's stated floor.
Five HCA-affiliated hospitals in Texas have sued Independence Blue Cross, a Philadelphia-based insurer, over $345,000 in allegedly denied or underpaid claims for eight members, including emergency care. The lawsuit claims the insurer violated federal and state law by requiring prior authorization for emergency services and failing to provide specific clinical reasons for denials. This dispute highlights ongoing issues within the BlueCard Program regarding varying authorization rules and medical necessity standards across different Blue Cross Blue Shield plans.
This article highlights three momentum anomaly stocks — Centene Corp. (CNC), BrightSpring Health Services, Inc. (BTSG), and Delek US Holdings, Inc. (DK) — that Zacks recommends buying as markets surge due to an AI rally. It explains momentum investing as a strategy to profit from continuing stock trends, especially when value or growth investing underperforms. The selected companies, despite recent short-term pullbacks, have shown significant price gains over the past year and boast a Momentum Score of A.
Centene Corp. stock (CNC) fell 2.60% on Tuesday, closing at $63.30, while the broader market showed mixed results with the S&P 500 largely unchanged and the Dow Jones Industrial Average experiencing a slight decline. This marked the third consecutive day of losses for Centene Corp.
Centene (CNC) stock has significantly outperformed its Medical sector peers and its specific industry group, Medical - HMOs, with a year-to-date return of 57.9% compared to the sector's 2.3% and the industry's 16.3%. The company holds a Zacks Rank of #1 (Strong Buy), supported by a 42.2% increase in its full-year earnings consensus estimate over the past 90 days. Alzamend Neuro, Inc. (ALZN) is another Medical stock showing strong performance, with a 6.6% year-to-date return and a Zacks Rank #2 (Buy).
This article identifies three growth stocks, ATI Inc., KE Holdings Inc., and Centene Corporation, that Zacks Investment Research recommends for September 22nd. Each company holds a Zacks Rank #1 (Strong Buy) and exhibits strong growth characteristics based on increased earnings estimates and favorable PEG ratios compared to their respective industries. The article details their recent earnings estimate increases and PEG ratios, highlighting Centene Corporation's impressive 40.9% earnings estimate increase.